Promising Penny Stocks To Watch Now – November 15th

Leap Therapeutics, Cypherpunk Technologies, and Invivyd are the three Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small companies—commonly defined in the U.S. as trading under $5 per share—and are often found on over‑the‑counter (OTC) markets rather than major exchanges. They are highly speculative and illiquid, with wide bid‑ask spreads, limited publicly available information, and elevated risk of price volatility or fraud. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Leap Therapeutics (LPTX)

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers.

Cypherpunk Technologies (CYPH)

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501.

Invivyd (IVVD)

Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.